Showing results (21-30 of 258) with videos related to
Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2012
Hsp90 molecular chaperone inhibitors: are we there yet?Len Neckers, Paul WorkmanExpert Opinion on Emerging Drugs|March 11, 2005
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an updateLen Neckers, Katharine NeckersFuture Oncology (London, England)|August 17, 2012
The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activityWanping Xu, Len NeckersBiochimica Et Biophysica Acta|August 23, 2011
Post-translational modifications of Hsp90 and their contributions to chaperone regulationMehdi Mollapour, Len NeckersExpert Opinion on Emerging Drugs|July 2, 2005
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agentsLen Neckers, Katharine NeckersACS Chemical Biology|December 14, 2006
Tumor selectivity of Hsp90 inhibitors: the explanation remains elusiveGabriela Chiosis, Len NeckersLung Cancer (Amsterdam, Netherlands)|November 16, 2004
Epithelial-directed drug delivery: influence of formulation and delivery devicesJames L Mulshine, Len NeckersAdvances in Cancer Research|February 27, 2016
Hsp90 in Cancer: Transcriptional Roles in the NucleusStuart K Calderwood, Len NeckersPageof 26